# Lamotrigine Extended-Release

NDC: 10370-334
Generic name: lamotrigine
Labeler / Manufacturer: Par Health USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20260102

FDA application: ANDA201374

## Active ingredients

- LAMOTRIGINE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10370-334"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10370-334
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d5ec4d58-c669-4ab4-ba62-b71007536854